Mc Lean Asset Management Corp Gilead Sciences, Inc. Transaction History
Mc Lean Asset Management Corp
- $558 Billion
- Q4 2025
A detailed history of Mc Lean Asset Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Lean Asset Management Corp holds 1,797 shares of GILD stock, worth $222,989. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,797
Previous 1,784
0.73%
Holding current value
$222,989
Previous $203 Million
10.03%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,394Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...